These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 37342994)

  • 41. Cellular association, intracellular distribution, and efflux of auranofin via sequential ligand exchange reactions.
    Snyder RM; Mirabelli CK; Crooke ST
    Biochem Pharmacol; 1986 Mar; 35(6):923-32. PubMed ID: 3082334
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Gold(I)-triphenylphosphine complexes with hypoxanthine-derived ligands: in vitro evaluations of anticancer and anti-inflammatory activities.
    Křikavová R; Hošek J; Vančo J; Hutyra J; Dvořák Z; Trávníček Z
    PLoS One; 2014; 9(9):e107373. PubMed ID: 25226034
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Reactions of model proteins with aurothiomalate, a clinically established gold(I) drug: The comparison with auranofin.
    Darabi F; Marzo T; Massai L; Scaletti F; Michelucci E; Messori L
    J Inorg Biochem; 2015 Aug; 149():102-7. PubMed ID: 25865000
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Mitochondrial thioredoxin reductase inhibition by gold(I) compounds and concurrent stimulation of permeability transition and release of cytochrome c.
    Rigobello MP; Scutari G; Folda A; Bindoli A
    Biochem Pharmacol; 2004 Feb; 67(4):689-96. PubMed ID: 14757168
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Progress in the characterization of gold drugs.
    Grootveld MC; Razi MT; Sadler PJ
    Clin Rheumatol; 1984 Mar; 3 Suppl 1():5-16. PubMed ID: 6432413
    [TBL] [Abstract][Full Text] [Related]  

  • 46. NMR reveals the metabolic changes induced by auranofin in A2780 cancer cells: evidence for glutathione dysregulation.
    Ghini V; Senzacqua T; Massai L; Gamberi T; Messori L; Turano P
    Dalton Trans; 2021 May; 50(18):6349-6355. PubMed ID: 33885689
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A biscarbene gold(I)-NHC-complex overcomes cisplatin-resistance in A2780 and W1 ovarian cancer cells highlighting pERK as regulator of apoptosis.
    König P; Zhulenko R; Suparman E; Hoffmeister H; Bückreiß N; Ott I; Bendas G
    Cancer Chemother Pharmacol; 2023 Jul; 92(1):57-69. PubMed ID: 37272932
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Gold Metallodrugs to Target Coronavirus Proteins: Inhibitory Effects on the Spike-ACE2 Interaction and on PLpro Protease Activity by Auranofin and Gold Organometallics*.
    Gil-Moles M; Basu U; Büssing R; Hoffmeister H; Türck S; Varchmin A; Ott I
    Chemistry; 2020 Nov; 26(66):15140-15144. PubMed ID: 32915473
    [TBL] [Abstract][Full Text] [Related]  

  • 49. New uses for old drugs. Auranofin, a clinically established antiarthritic metallodrug, exhibits potent antimalarial effects in vitro: Mechanistic and pharmacological implications.
    Sannella AR; Casini A; Gabbiani C; Messori L; Bilia AR; Vincieri FF; Majori G; Severini C
    FEBS Lett; 2008 Mar; 582(6):844-7. PubMed ID: 18294965
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Evaluation of Auranofin Loading within Ferritin Nanocages.
    Lucignano R; Pratesi A; Imbimbo P; Monti DM; Picone D; Messori L; Ferraro G; Merlino A
    Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430642
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The antioxidant 2,6-di-tert-butylphenol moiety attenuates the pro-oxidant properties of the auranofin analogue.
    Shpakovsky DB; Shtil AA; Kharitonashvili EV; Tyurin VY; Antonenko TA; Nazarov AA; Osipova VP; Berberova NT; Foteeva LS; Schmidt C; Ott I; Milaeva ER
    Metallomics; 2018 Mar; 10(3):406-413. PubMed ID: 29399682
    [TBL] [Abstract][Full Text] [Related]  

  • 52. ESI MS studies highlight the selective interaction of Auranofin with protein free thiols.
    Zoppi C; Messori L; Pratesi A
    Dalton Trans; 2020 May; 49(18):5906-5913. PubMed ID: 32314767
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Characterization of the in vitro effect of triethylphosphine gold (auranofin) on human NK cell activity.
    Pedersen BK; Abom B
    Clin Exp Rheumatol; 1986; 4(3):249-53. PubMed ID: 3490341
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Broad Spectrum Functional Activity of Structurally Related Monoanionic Au(III) Bis(Dithiolene) Complexes.
    Le Gal Y; Filatre-Furcate A; Lorcy D; Jeannin O; Roisnel T; Dorcet V; Fontinha D; Francisco D; Prudncio M; Martins M; Soeiro C; Sousa SA; Leitão JH; Morais TS; Bártolo I; Taveira N; Guerreiro JF; Marques F
    Int J Mol Sci; 2022 Jun; 23(13):. PubMed ID: 35806151
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Thiol competition for Et3PAuS-albumin: a nonenzymatic mechanism for Et3PO formation.
    Coffer MT; Shaw CF; Hormann AL; Mirabelli CK; Crooke ST
    J Inorg Biochem; 1987 Jul; 30(3):177-87. PubMed ID: 3655788
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Gold(I) ion and the phosphine ligand are necessary for the anti-
    Ma CI; Tirtorahardjo JA; Schweizer SS; Zhang J; Fang Z; Xing L; Xu M; Herman DA; Kleinman MT; McCullough BS; Barrios AM; Andrade RM
    Microbiol Spectr; 2024 Feb; 12(2):e0296823. PubMed ID: 38206030
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Gold(I) complexes with thiosemicarbazones: cytotoxicity against human tumor cell lines and inhibition of thioredoxin reductase activity.
    Lessa JA; Guerra JC; de Miranda LF; Romeiro CF; Da Silva JG; Mendes IC; Speziali NL; Souza-Fagundes EM; Beraldo H
    J Inorg Biochem; 2011 Dec; 105(12):1729-39. PubMed ID: 22005449
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Repurposing of auranofin: Thioredoxin reductase remains a primary target of the drug.
    Zhang X; Selvaraju K; Saei AA; D'Arcy P; Zubarev RA; Arnér ES; Linder S
    Biochimie; 2019 Jul; 162():46-54. PubMed ID: 30946948
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Inhibition of cathepsin B by Au(I) complexes: a kinetic and computational study.
    Gunatilleke SS; de Oliveira CA; McCammon JA; Barrios AM
    J Biol Inorg Chem; 2008 May; 13(4):555-61. PubMed ID: 18253767
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Mononuclear gold(III) complexes with phenanthroline ligands as efficient inhibitors of angiogenesis: A comparative study with auranofin and sunitinib.
    Pavic A; Glišić BĐ; Vojnovic S; Warżajtis B; Savić ND; Antić M; Radenković S; Janjić GV; Nikodinovic-Runic J; Rychlewska U; Djuran MI
    J Inorg Biochem; 2017 Sep; 174():156-168. PubMed ID: 28675847
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.